Paper · 34557710
Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery.
Zhao K and 2 others. Innovation (Camb), 2020. Cited by 67 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery. Papers, record 34557710. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34557710
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References163
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,704,925 | Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. | J Virol | 1991 | https://conductscience.org/library/papers/1704925 | PubMed |
| 2 | 19,574,418 | Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. | J Natl Cancer Inst | 2009 | https://conductscience.org/library/papers/19574418 | PubMed |
| 3 | 20,519,397 | Clonal expansion of normal-appearing human hepatocytes during chronic hepatitis B virus infection. | J Virol | 2010 | https://conductscience.org/library/papers/20519397 | PubMed |
| 4 | 22,379,076 | In vitro epsilon RNA-dependent protein priming activity of human hepatitis B virus polymerase. | J Virol | 2012 | https://conductscience.org/library/papers/22379076 | PubMed |
| 5 | 6,268,980 | Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. | N Engl J Med | 1981 | https://conductscience.org/library/papers/6268980 | PubMed |
| 6 | 8,707,245 | Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. | Hepatology | 1996 | https://conductscience.org/library/papers/8707245 | PubMed |
| 7 | 26,239,691 | Present and future therapies of hepatitis B: From discovery to cure. | Hepatology | 2015 | https://conductscience.org/library/papers/26239691 | PubMed |
| 8 | 26,231,459 | Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. | Lancet | 2015 | https://conductscience.org/library/papers/26231459 | PubMed |
| 9 | 14,633,616 | Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. | Am J Pathol | 2003 | https://conductscience.org/library/papers/14633616 | PubMed |
| 10 | 1,690,862 | Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription. | Nature | 1990 | https://conductscience.org/library/papers/1690862 | PubMed |
1 to 10 of 163
See all 163 referencesCited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,503,913 | [Clinical significance and occurrence mechanism of hepatitis B virus DNA integration]. | Zhonghua Gan Zang Bing Za Zhi | 2026 | https://conductscience.org/library/papers/42503913 | PubMed |
| 42,400,106 | Sex Hormone Receptors, HBV Integrations and Their Prognostic Predictive Value Among Hepatocellular Carcinoma Patients. | Int J Cancer | 2026 | https://conductscience.org/library/papers/42400106 | PubMed |
| 42,258,089 | Landscape and biogenesis of piRNAs in HBV-associated hepatocarcinogenesis: from repetitive elements to oncogenic circuits. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42258089 | PubMed |
| 42,151,659 | A Fluorescence Imaging- and Deep Learning-Based Approach for Detecting Hepatitis B Virus Integration into Host Genomes. | J Imaging Inform Med | 2026 | https://conductscience.org/library/papers/42151659 | PubMed |
| 41,770,665 | HBV Integration in Clinical Management of Hepatocellular Carcinoma by Liquid Biopsy. | Oncology | 2026 | https://conductscience.org/library/papers/41770665 | PubMed |
| 41,174,783 | Exploratory analysis of lamivudine legacy and clonal selection of HBs truncation mutants in HBV-related hepatocellular carcinoma. | Infect Agent Cancer | 2025 | https://conductscience.org/library/papers/41174783 | PubMed |
| 40,957,658 | Long-read sequencing reveals HBV integration patterns and oncogenic impact on early-onset hepatocellular carcinoma. | Genome Res | 2025 | https://conductscience.org/library/papers/40957658 | PubMed |
| 40,948,758 | Targeting archetypes of viral-driven cancers with immunotherapy: a perspective on immunogenicity within the tumor microenvironment. | Front Immunol | 2025 | https://conductscience.org/library/papers/40948758 | PubMed |
| 40,703,675 | Historical and Emerging Trends in Hepatitis B Virus Integration: A Bibliometric Visual Analysis. | Hepat Med | 2025 | https://conductscience.org/library/papers/40703675 | PubMed |
| 40,584,295 | Circular RNAs in hepatitis B virus-induced hepatocellular carcinoma: A comprehensive review and recent advances. | Genes Dis | 2025 | https://conductscience.org/library/papers/40584295 | PubMed |
1 to 10 of 44
See all 44 cited byGenes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCNE1 | 898 | PubTator's text mining | https://conductscience.org/library/genes/898 | NCBI Gene |
| CCNL2 | 81,669 | PubTator's text mining | https://conductscience.org/library/genes/81669 | NCBI Gene |
| ELF4 | 2,000 | PubTator's text mining | https://conductscience.org/library/genes/2000 | NCBI Gene |
| ESPL1 | 9,700 | PubTator's text mining | https://conductscience.org/library/genes/9700 | NCBI Gene |
| FEN1 | 2,237 | PubTator's text mining | https://conductscience.org/library/genes/2237 | NCBI Gene |
| KMT2A | 4,297 | PubTator's text mining | https://conductscience.org/library/genes/4297 | NCBI Gene |
| KMT2B | 9,757 | PubTator's text mining | https://conductscience.org/library/genes/9757 | NCBI Gene |
| LY75 | 4,065 | PubTator's text mining | https://conductscience.org/library/genes/4065 | NCBI Gene |
| POLA1 | 5,422 | PubTator's text mining | https://conductscience.org/library/genes/5422 | NCBI Gene |
| PRDM9 | 56,979 | PubTator's text mining | https://conductscience.org/library/genes/56979 | NCBI Gene |
1 to 10 of 15
See all 15 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34557710
GET https://conductscience.org/api/papers/v1/34557710/references?page=2